Some providers prescribe semaglutide at doses up to 3 mg or higher for patients who plateau below goal weight at 2.4 mg
Qsymia is one of the more effective oral weight loss medications available, combining phentermine and topiramate for stronger appetite suppression than either drug alone
GLP-1 receptor agonists, often referred to simply as GLP-1s, have emerged as a promising option
For many patients, this translates into easier portion control, fewer binges, and a more comfortable, gradual reduction in weight over time
Metabolomic study of lipids in serum for biomarker discovery in Alzheimers disease using direct infusion mass spectrometry
Semaglutide may help more patients actually reach and maintain these thresholds by making appetite and portion control more manageable over the long term